In “Unexpected Cytomegalovirus (CMV) Replication Kinetics in CMV Donor-Seropositive, Recipient-Seronegative Liver Transplant Recipients Receiving Preemptive Antiviral Therapy” by Singh et al [J Infect Dis 2022; jiab132], a source of funding was omitted. The correct funding statement should read: Trial support was provided by the National Institute of Allergy and Infectious Diseases of the NIH (contract number HHSN272201100041C) and the National Institutes of Health’s Heart, Lung, and Blood Institute and Institute of Allergy and Infectious Diseases [AI163090 to A.P.L.]. The authors regret the error.
. 2022 Aug 11;227(5):737. doi: 10.1093/infdis/jiac125
Correction to: Unexpected Cytomegalovirus (CMV) Replication Kinetics in CMV Donor-Seropositive, Recipient-Seronegative Liver Transplant Recipients Receiving Preemptive Antiviral Therapy
Collection date 2023 Mar 1.
© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/pages/standard-publication-reuse-rights)
PMCID: PMC9978307 PMID: 35951429
This corrects the article "Unexpected Cytomegalovirus (CMV) Replication Kinetics in CMV Donor-Seropositive, Recipient-Seronegative Liver Transplant Recipients Receiving Preemptive Antiviral Therapy" in volume 225 on page 436.
